NLS PHARMACEUTICS LTD's ticker is NLSPW and the CUSIP is H57830111. A total of 9 filers reported holding NLS PHARMACEUTICS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,895 | -1.7% | 170,100 | 0.0% | 0.12% | +6.1% |
| Q2 2023 | $18,201 | -28.7% | 170,100 | 0.0% | 0.11% | +23.9% |
| Q1 2023 | $25,515 | -48.3% | 170,100 | 0.0% | 0.09% | -31.9% |
| Q4 2022 | $49,329 | +14.7% | 170,100 | 0.0% | 0.14% | +80.0% |
| Q3 2022 | $43,000 | +115.0% | 170,100 | 0.0% | 0.08% | +134.4% |
| Q2 2022 | $20,000 | -69.2% | 170,100 | 0.0% | 0.03% | -61.9% |
| Q1 2022 | $65,000 | -23.5% | 170,100 | 0.0% | 0.08% | +5.0% |
| Q4 2021 | $85,000 | – | 170,100 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 827,921 | $2,069,000 | 0.44% |
| Worth Venture Partners, LLC | 194,560 | $161,000 | 0.07% |
| ARMISTICE CAPITAL, LLC | 500,000 | $413,000 | 0.01% |
| Warberg Asset Management LLC | 35,480 | $29,000 | 0.01% |
| Hudson Bay Capital Management LP | 200,000 | $154,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 2,635 | $2,000 | 0.00% |
| Bank Julius Baer & Co. Ltd, Zurich | 7,370 | $6,000 | 0.00% |